Loading...
  • infusion
  • 8. A method for the treatment of a patient having a tumor, wherein the method includes the step of injecting an infusion solution that contains the cell population with anti-tumor immune response activity prepared by the method of claim 1 intoa cancer patient in need of the treatment, wherein the mononuclear cells are derived from the patient. (patentgenius.com)
  • For children with PJIA, it is given once every four weeks as an intravenous infusion or once every two - three weeks as a subcutaneous injection depending on weight. (rheumatology.org)
  • Tocilizumab infusion or injection should not be given if an adult or child is actively ill with an illness or high fever at the time the medication is due. (rheumatology.org)
  • vials
  • Terbutaline sulfate, USP, the active ingredient of terbutaline sulfate injection, is a beta-adrenergic agonist bronchodilator available as a sterile, nonpyrogenic, aqueous solution in vials, for subcutaneous administration. (nih.gov)
  • Adults
  • Relistor tablets and Relistor injection are used to treat constipation caused by opioids in adults with chronic (long-lasting) pain that is not caused by cancer. (pdr.net)
  • Relistor injection is used to treat constipation caused by opioids in adults who are receiving treatment for advanced illness, when other medicines for constipation have not worked well enough. (pdr.net)
  • Adult
  • Subcutaneous administration of 0.5 mg of terbutaline sulfate to 17 healthy, adult, male subjects resulted in mean (SD) peak plasma terbutaline concentration of 9.6 (3.6) ng/mL, which was observed at a median (range) time of 0.5 (0.08 to 1.0) hours after dosing. (nih.gov)
  • The adult dosage of enfuvirtide is 90 mg per injection, twice a day. (aidsinfonet.org)
  • Interactions
  • These protein nanoclusters are ideal for subcutaneous delivery as they have low interactions between the colloids, are reversible in nature, and dissolve rapidly upon dilution in a buffer media. (utexas.edu)
  • site
  • The injection may start to start to work at different speeds depending on the site you use and various other factors, such as if you have been doing exercise. (netdoctor.co.uk)
  • Each time you inject your insulin make sure you use a different site. (netdoctor.co.uk)
  • The site of injection should be rotated so the same site is not used multiple times. (rheumatology.org)
  • Combined with a one-handed injection technique and its ability to facilitate flexible site rotation, BD Ultra-Fine Nano may help improve adherence to diabetes therapy regimens to support better health outcomes. (mdtmag.com)
  • A drop of blood may appear at the administration site following injection. (drugs.com)
  • In the event of an improperly performed injection (ie, no bleb formed), repeat the test immediately at another site, at least 2 inches from the first site and circle the second injection site as an indication that this is the site to be read. (drugs.com)
  • Measure the diameter of induration transversely to the long axis of the forearm and record the measurement in millimeters (including 0 mm). (8) The tip of a ballpoint pen, gently pushed at a 45° angle toward the site of injection, will stop at the edge of induration. (drugs.com)
  • Administration
  • After subcutaneous administration of 0.25 mg of terbutaline sulfate injection, a measurable change in expiratory flow rate usually occurs within 5 minutes, and a clinically significant increase in FEV1 occurs within 15 minutes. (nih.gov)
  • After subcutaneous administration of 0.25 mg of terbutaline sulfate to two male subjects, peak terbutaline serum concentrations of 5.2 and 5.3 ng/mL were observed at about 20 minutes after dosing. (nih.gov)
  • Tresiba is supplied as an injection for subcutaneous administration. (centerwatch.com)
  • Diabetes
  • People with type 1 diabetes need to have injections of insulin to control the amount of glucose in their bloodstream. (netdoctor.co.uk)
  • We are excited to provide another first-to-market innovation, designed to dramatically improve the injection experience for the millions of people living with diabetes," commented Linda Tharby, President, BD Medical - Diabetes Care. (mdtmag.com)
  • Asia Pacific is also one of the fast-growing regions in the global subcutaneous injection ports market due to high incidence of diabetes in low-income countries. (medgadget.com)